Dolores Schendel
The Power List 2020 – Advanced Medicine
![](/fileadmin/_processed_/c/2/csm_Schendel_5cd5f907da.png)
Chief Executive Officer and Chief Scientific Officer at Medigene
Schendel has been a member of the German Research Foundation, German Cancer Aid and the European Research Council, and developed her interest in tumor immunology while working at the Sloan-Kettering Institute in New York. In 2019, Medigene commenced a phase I/II trial of its first TCR-T immunotherapy against several blood cancers.
![](/fileadmin/_processed_/3/c/csm_PL_2020_11ef01e268.png)